G6PD and G6PD deficiency: In agreement with our results, Koriem et al[49] a study published in 2017, showed that G6PD deficiency patients with favism who take VitE for one month had a high level of hemoglobin, hematocrit, and serum G6PD, which was dose-dependent, increasing the dose of VitE was associated with better outcomes.